Background Extracorporeal membrane oxygenation (ECMO) has been widely used in
patients with COVID-19, but uncertainty remains about the determinants of in-hospital …

High-volume extracorporeal membrane oxygenation (ECMO) centers generally have better
outcomes than (new) low-volume ECMO centers, most likely achieved by a suitable …

Extracorporeal membrane oxygenation (ECMO) has now been successfully delivered to
children 1 and young adults 2 for more than 50 years. ECMO is an invasive life support …

Rationale: Definitive guidelines for anticoagulation management during veno-venous
extracorporeal membrane oxygenation (VV ECMO) are lacking, whereas bleeding …

Background The COVID-19 pandemic has increased the number of patients in ICUs leading
to a worldwide shortage of the intravenous sedative agents obligating physicians to find …

Introduction: The effectiveness of extracorporeal membrane oxygenation (ECMO) in treating
COVID-19 patients has been variable. To gain a better insight, we examined the outcomes …

Background To inform future research and practice, we aimed to investigate the outcomes of
patients who received extracorporeal membrane oxygenation (ECMO) for acute respiratory …

Introduction Venovenous extracorporeal membrane oxygenation (VV ECMO) can be
considered in critically ill patient in severe pulmonary failure. However, the mobilization of …

Rationale: Severe cases of acute respiratory distress syndrome (ARDS) may require
prolonged (> 28 d) extracorporeal membrane oxygenation (ECMO). In nonresolving …

Extracorporeal membrane oxygenation (ECMO) has been used in highly selected COVID-19
patients with severe respiratory failure. Scarce data exist on long-term outcomes of these …